5[6]Allison A C.Squalene and squalane emulsions as adjuvants.Methods,1999,19:87 ～ 93. 被引量：1
6[7]Altman A,Dixon F J.Immunomodifiers in vaccines.Adv Vet Sci Comp Med,1989,33:301 ～ 343. 被引量：1
7[8]Beacock-Sharp H,Donachie A M,Robson N C,et al.A role for dendritic cells in the priming of antigen-specific CD4 + and CD8 + T lymphocytes by immune-stimulating complexes in vivo.Int Immunol,2003,15:711 ～ 720. 被引量：1
8[9]Bonadonna G,Moliterni A,Zambetti M,et al.30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer:cohort study.BMJ,2005,330(7 485):217. 被引量：1
9[10]Bonifaz L C,Bonnyay D P,Charalambous A,et al.In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination.J Exp Med,2004,199:815 ～ 824. 被引量：1
10[11]Cox J C,Coulter A R.Adjuvants-a classification and review of the modes of action.Vaccine,1997,15:248 ～ 256. 被引量：1
6Al-akhohir R H, Regnier F E, White J L, et al. Contribution of electrostatic and hydrophobic interactions to the adsorption of protein by aluminium containing adjuvants[J]. Vaccine, 1995,13(1):41-43. 被引量：1
